Prof. François Mach is full Professor of cardiology at Geneva University Hospital and head of Cardiology Department since 2006. He completed a post-doctoral fellowship in the laboratory of Prof. Peter Libby, Brigham and Women’s Hospital, Boston (1995-1999). Between 2012-14, he was the President of the Swiss Society of Cardiology. He is the author of more than 500 high impact factor publications. As director of the atherosclerosis basic science laboratory, he and his research group have substantially contributed to a better clarification of the inflammatory mechanisms underlying atherosclerosis and its acute complications, both in human cohorts and animal studies. For several years now, he has also been strongly implicated in clinical research in the field of prevention, especially lipidology, by contributing to the design and completion of several clinical research projects and multi-center studies. He is also responsible of several Swiss cohorts of atherothrombotic patients, and is one of the 3 co-chairs of the ESC/EAS 2019 Lipid Guidelines, as well as co-chair of the ESC 2021 Prevention Guidelines.


Implementation of the 2019 lipid guidelines-where are we now? - Discussion and Q&A90th EAS Congress 2022Implementation of the 2019 lipid guidelines-where are we now?Slow and sure wins the race- a stepwise approach90th EAS Congress 2022Implementation of the 2019 lipid guidelines-where are we now?Are the new EAS-ESC lipids goals reachable in clinical practice?88th EAS Congress 2020PCSK9 inhibition in clinical practice87th EAS Congress 2019